Does TECLISTAMAB-CQYV Cause Hypercalcaemia? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hypercalcaemia have been filed in association with TECLISTAMAB-CQYV. This represents 0.4% of all adverse event reports for TECLISTAMAB-CQYV.
7
Reports of Hypercalcaemia with TECLISTAMAB-CQYV
0.4%
of all TECLISTAMAB-CQYV reports
1
Deaths
5
Hospitalizations
How Dangerous Is Hypercalcaemia From TECLISTAMAB-CQYV?
Of the 7 reports, 1 (14.3%) resulted in death, 5 (71.4%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Hypercalcaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Hypercalcaemia?
RITUXIMAB (857)
METHOTREXATE (803)
ADALIMUMAB (663)
TOCILIZUMAB (618)
ABATACEPT (612)
ETANERCEPT (602)
DENOSUMAB (599)
ALENDRONATE (594)
INFLIXIMAB (594)
LEFLUNOMIDE (585)
Which TECLISTAMAB-CQYV Alternatives Have Lower Hypercalcaemia Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL